Men treated with testosterone replacement therapy (TRT) for hypogonadism didn't have an increase in adverse prostate events, the TRAVERSE trial found. Over a mean follow-up of 33 months, those who ...

SCOTTSDALE, Ariz. – Men with hypogonadism who developed deep vein thromboses (DVTs) weren't more likely to have recently been on testosterone-replacement therapy (TRT), a new study found, challenging ...

This article was reviewed by Felix Gussone, MD. Key Takeaways: Testosterone does more than drive puberty. It influences drive ...

Testosterone replacement therapy (TRT) in men with secondary hypogonadism due to nonfunctioning pituitary adenomas or prolactinomas is associated with a significantly lower risk of major adverse ...

The incidence of hypogonadism and use of testosterone replacement therapy (TRT) are rising, while data evaluating the complexity and quality of health-care information available to patients on the ...

Hims announced that TRT therapy would be coming to its telehealth platform this year. But a grey market still thrives as recreational use supersedes medical needs.

New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase. RJK Jr. has explored a few controversial ideas, particularly in ...

Independent analysis examines Fridays' published TRT program structure, delivery format options, and what clinical research indicates for men evaluating prescription testosterone pathways heading into ...

Testosterone is a male sex hormone that plays a crucial role in the body, helping maintain muscle and bone health, regulating fat distribution and the production of sperm and red blood cells. Your ...